
7.75 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 4.77 Today|||52-Week Range 14.34 | +27.05% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $338.0M |
Voyager Therapeutics, Inc. 64 Sidney Street Cambridge Massachusetts 02139 |
Alfred W. Sandrock | President, Chief Executive Officer & Director |
Robin Swartz | Chief Operating Officer |
Peter P. Pfreundschuh | Chief Financial & Accounting Officer |
Todd Carter | Chief Scientific Officer |
Julie Burek | Vice President-Finance |